Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Harrison

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
BMC Genomics|March 12, 2017
Genome analysis following a national increase in Scarlet Fever in England 2014Victoria Chalker, Aleksey Jironkin, Juliana Coelho, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Spirocyclic NK(1) antagonists I: [4.5] and [5.5]-spiroketalsEileen M Seward, Emma Carlson, Timothy Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane coreStephen J Lewis, Adrian L Smith, Joseph G Neduvelil, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 2006
The novel gamma secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouseJonathan D Best, David W Smith, Michael A Reilly, et al.
Chemistry & Biology|February 24, 2007
Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signalingHuw D Lewis, Matthew Leveridge, Peter R Strack, et al.
Molecular Cancer Therapeutics|July 31, 2016
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung CancerKylie A McLaughlin, Zsuzsanna Nemeth, Conor A Bradley, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Journal of Medicinal Chemistry|May 13, 2009
Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activityLinda E Keown, Ian Collins, Laura C Cooper, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
JAMA Internal Medicine|September 23, 2016
Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical TrialSebastian L Johnston, Matyas Szigeti, Mary Cross, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
BMC Genomics|March 12, 2017
Genome analysis following a national increase in Scarlet Fever in England 2014Victoria Chalker, Aleksey Jironkin, Juliana Coelho, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Spirocyclic NK(1) antagonists I: [4.5] and [5.5]-spiroketalsEileen M Seward, Emma Carlson, Timothy Harrison, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
A novel series of potent gamma-secretase inhibitors based on a benzobicyclo[4.2.1]nonane coreStephen J Lewis, Adrian L Smith, Joseph G Neduvelil, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 14, 2006
The novel gamma secretase inhibitor N-[cis-4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)cyclohexyl]-1,1,1-trifluoromethanesulfonamide (MRK-560) reduces amyloid plaque deposition without evidence of notch-related pathology in the Tg2576 mouseJonathan D Best, David W Smith, Michael A Reilly, et al.
Chemistry & Biology|February 24, 2007
Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signalingHuw D Lewis, Matthew Leveridge, Peter R Strack, et al.
Molecular Cancer Therapeutics|July 31, 2016
FLIP: A Targetable Mediator of Resistance to Radiation in Non-Small Cell Lung CancerKylie A McLaughlin, Zsuzsanna Nemeth, Conor A Bradley, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2015
Development of a potent and selective cell penetrant Legumain inhibitorKerry A Ness, Sharon L Eddie, Catherine A Higgins, et al.
Journal of Medicinal Chemistry|May 13, 2009
Novel orally bioavailable gamma-secretase inhibitors with excellent in vivo activityLinda E Keown, Ian Collins, Laura C Cooper, et al.
The Lancet. Respiratory Medicine|October 7, 2021
Oral corticosteroid elimination via a personalised reduction algorithm in adults with severe, eosinophilic asthma treated with benralizumab (PONENTE): a multicentre, open-label, single-arm studyAndrew Menzies-Gow, Mark Gurnell, Liam G Heaney, et al.
JAMA Internal Medicine|September 23, 2016
Azithromycin for Acute Exacerbations of Asthma : The AZALEA Randomized Clinical TrialSebastian L Johnston, Matyas Szigeti, Mary Cross, et al.
Pageof 8